Panacea Of India Cleared By WHO To Resume Five-Disease Vaccine
This article was originally published in PharmAsia News
Executive Summary
India's Panacea Biotec reports it has been absolved of any link between its EasyFive five-in-one vaccine and incidents of infant deaths